Metabolomics Non Selection Study - Vitrolife Media

Key facts

Sponsor

Overture Life

Principal Investigator

Jose Horcajadas, PhD

Overture Life

Intervention

Overture Metabolomics Embryo Selection(diagnostic_test)

Enrollment

205 target

Eligibility

18-38 years · FEMALE

Timeline

2021 – 2024

Study locations (2)

• Grupo Procrearte, Buenos Aires, Argentina
• Clinical Juana Crespo, Valencia, Spain

Collaborators

Clinica Juana Crespo · Grupo Procrearte

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Genetic infertility

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGNANCT07369362
  To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles.
  MotilityCount aps
• ENROLLING BY INVITATIONNCT06419127
  Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation Sequencing
  Gattaca Genomics
• RECRUITINGNANCT06023472
  Microfluidic Chip vs Density Gradient Centrifugation on the Euploidy Rate of Pre-implantation Genetic Testing
  Professor Ernest Hung-Yu Ng
• RECRUITINGNANCT06358547
  Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Women Aged 37-41 Years
  Rigshospitalet, Denmark
• RECRUITINGNANCT06261671
  Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates.
  ART Fertility Clinics LLC
• ACTIVE NOT RECRUITINGNANCT04744025
  Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates
  Lawrence Engmann
• RECRUITINGNCT04528498
  Embryo Health Study
  Genomic Prediction Inc.
• RECRUITINGNCT04477863
  Follow-up With Preimplantation Genetic Testing Patients
  Genomic Prediction Inc.

See all trials for Genetic infertility →